These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 19192642)

  • 1. VEGF-1 expression in colorectal cancer is associated with disease localization, stage, and long-term disease-specific survival.
    Bendardaf R; Buhmeida A; Hilska M; Laato M; Syrjänen S; Syrjänen K; Collan Y; Pyrhönen S
    Anticancer Res; 2008; 28(6B):3865-70. PubMed ID: 19192642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological correlation and prognostic significance of VEGF-A, VEGF-C, VEGFR-2 and VEGFR-3 expression in colorectal cancer.
    Martins SF; Garcia EA; Luz MA; Pardal F; Rodrigues M; Filho AL
    Cancer Genomics Proteomics; 2013; 10(2):55-67. PubMed ID: 23603341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.
    Hu WG; Li JW; Feng B; Beveridge M; Yue F; Lu AG; Ma JJ; Wang ML; Guo Y; Jin XL; Zheng MH
    Eur Surg Res; 2007; 39(4):229-38. PubMed ID: 17446709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor receptor expression as a prognostic marker for survival in colorectal cancer.
    Okita NT; Yamada Y; Takahari D; Hirashima Y; Matsubara J; Kato K; Hamaguchi T; Shirao K; Shimada Y; Taniguchi H; Shimoda T
    Jpn J Clin Oncol; 2009 Sep; 39(9):595-600. PubMed ID: 19535387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA image cytometry predicts disease outcome in stage II colorectal carcinoma.
    Buhmeida A; Hilska M; Elzagheid A; Laato M; Collan Y; Syrjänen K; Pyrhönen S
    Anticancer Res; 2009 Jan; 29(1):99-106. PubMed ID: 19331138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deleted in colorectal cancer protein expression as a possible predictor of response to adjuvant chemotherapy in colorectal cancer patients.
    Gal R; Sadikov E; Sulkes J; Klein B; Koren R
    Dis Colon Rectum; 2004 Jul; 47(7):1216-24. PubMed ID: 15148649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of VEGF expression evaluated by quantitative immunohistochemical analysis in colorectal cancer.
    Zafirellis K; Agrogiannis G; Zachaki A; Gravani K; Karameris A; Kombouras C
    J Surg Res; 2008 Jun; 147(1):99-107. PubMed ID: 17655863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of E-cadherin expression predicts disease recurrence and shorter survival in colorectal carcinoma.
    Elzagheid A; Buhmeida A; Laato M; El-Faitori O; Syrjänen K; Collan Y; Pyrhönen S
    APMIS; 2012 Jul; 120(7):539-48. PubMed ID: 22716209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor, CD68, and epidermal growth factor receptor expression and survival in patients with Stage II and Stage III colon carcinoma: a role for the host response in prognosis.
    Khorana AA; Ryan CK; Cox C; Eberly S; Sahasrabudhe DM
    Cancer; 2003 Feb; 97(4):960-8. PubMed ID: 12569594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-existence of cyclin D1 and vascular endothelial growth factor protein expression is a poor prognostic factor for UICC stage I-III colorectal cancer patients after curative resection.
    Tsai HL; Yeh YS; Chang YT; Yang IP; Lin CH; Kuo CH; Juo SH; Wang JY
    J Surg Oncol; 2013 Feb; 107(2):148-54. PubMed ID: 22926658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of vascular endothelial growth factor can predict event-free survival in stage II colon cancer.
    Cascinu S; Staccioli MP; Gasparini G; Giordani P; Catalano V; Ghiselli R; Rossi C; Baldelli AM; Graziano F; Saba V; Muretto P; Catalano G
    Clin Cancer Res; 2000 Jul; 6(7):2803-7. PubMed ID: 10914727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients.
    Al-Mulla F; Hagan S; Behbehani AI; Bitar MS; George SS; Going JJ; García JJ; Scott L; Fyfe N; Murray GI; Kolch W
    J Clin Oncol; 2006 Dec; 24(36):5672-9. PubMed ID: 17179102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up.
    Theodoropoulos GE; Karafoka E; Papailiou JG; Stamopoulos P; Zambirinis CP; Bramis K; Panoussopoulos SG; Leandros E; Bramis J
    Anticancer Res; 2009 Feb; 29(2):785-91. PubMed ID: 19331236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer.
    Carrillo de Santa Pau E; Arias FC; Caso Peláez E; Muñoz Molina GM; Sánchez Hernández I; Muguruza Trueba I; Moreno Balsalobre R; Sacristán López S; Gómez Pinillos A; del Val Toledo Lobo M
    Cancer; 2009 Apr; 115(8):1701-12. PubMed ID: 19197998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue microarray analysis of 560 patients with colorectal adenocarcinoma: high expression of HuR predicts poor survival.
    Yoo PS; Sullivan CA; Kiang S; Gao W; Uchio EM; Chung GG; Cha CH
    Ann Surg Oncol; 2009 Jan; 16(1):200-7. PubMed ID: 19009247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical expression of bcl-2 in UICC stage I and III colorectal carcinoma patients: correlation with c-erbB-2, p53, ki-67, CD44, laminin and collagen IV in evaluating prognostic significance.
    Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
    Pol J Pathol; 2006; 57(3):149-59. PubMed ID: 17219742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of carcinoembryonic antigen and vascular endothelial growth factor tumor tissue content in colorectal cancer.
    Ferroni P; Palmirotta R; Spila A; Martini F; Formica V; Portarena I; Del Monte G; Buonomo O; Roselli M; Guadagni F
    Oncology; 2006; 71(3-4):176-84. PubMed ID: 17652942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA image cytometry is a useful adjunct tool in the prediction of disease outcome in patients with stage II and stage III colorectal cancer.
    Buhmeida A; Algars A; Ristamäki R; Collan Y; Syrjänen K; Pyrhönen S
    Oncology; 2006; 70(6):427-37. PubMed ID: 17220640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue factor and vascular endothelial growth factor expression in colorectal cancer: relation with cancer recurrence.
    Altomare DF; Rotelli MT; Pentimone A; Rossiello MR; Martinelli E; Guglielmi A; De Fazio M; Marino F; Memeo V; Colucci M; Semeraro N
    Colorectal Dis; 2007 Feb; 9(2):133-8. PubMed ID: 17223937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.